MUC1 and neoplasm: The Tn glycan epitope presented on tumor-associated glycoproteins has also been demonstrated to be a target for macrophage galactose-type lectin receptor (MGL, CD301) which can discriminate between healthy and tumor-associated glycans of the mucin MUC1 (Saeland et al., 2007).